CLL Cello Health Plc

RNS No 2269u
CASSELL PLC
12th October 1998



This announcement is not for release, publication or distribution in or into
the United States, Canada, Australia or Japan
                                       
                                       
                                  Cash Offer
                                      by
                         Singer & Friedlander Limited
                                 on behalf of
                         Macmillan Publishers Limited
                            to acquire Cassell PLC


It  was  announced earlier today that Singer & Friedlander Limited ("Singer  &
Friedlander"),  on behalf of Macmillan Publishers Limited ("Macmillan"),  will
make  a  cash offer ("the Offer") for the whole of the issued and to be issued
ordinary share capital of Cassell PLC  ("Cassell"), which values each ordinary
share of Cassell at 100p and Cassell at approximately #7.3 million.

In  relation to the Offer, Macmillan has now received irrevocable undertakings
from certain institutional shareholders referred to below, to accept the Offer
in   respect   of,  in  aggregate,  1,100,931  ordinary  shares  of   Cassell,
representing  15 per cent. of the issued share capital of Cassell.   Macmillan
has  already  purchased 1,093,591 ordinary shares of Cassell from  certain  of
these  shareholders.   These purchases and irrevocable  undertakings  together
represent approximately 29.9 per cent. of the existing issued share capital of
Cassell.

Further details relating to these irrevocable undertakings are set out in the
announcement of the Offer made earlier today.

In addition, Macmillan has received intentions to support the Offer in respect
of, in aggregate, 2,493,978 ordinary shares of Cassell, representing
approximately 34.0 per cent. of the issued share capital of Cassell.  These
Cassell Shares when aggregated with the Cassell Shares already purchased and
the irrevocable undertakings already received by Macmillan represent
approximately 63.9 per cent. of the issued share capital of Cassell.

The  names  of  the institutional shareholders referred to above  are  Jupiter
Asset  Management  Limited  and  Jupiter Asset Management  (Bermuda)  Limited;
Herald  Investment  Management  Limited;  Mercury  Asset  Management  Limited;
INVESCO Asset Management Limited; Perpetual Unit Trust Management Limited; and
Phillips  &  Drew Fund Management Limited, each of whom has given  irrevocable
undertakings  in  respect  of 100,148 and 43,441; 181,747;  110,363;  291,171;
195,014; and 179,047 ordinary shares of Cassell respectively.

Enquiries:-

Macmillan Publishers Limited                      0171 881 8000
Richard Charkin

Singer & Friedlander Limited                      0171 623 3000
Graham Hall

Singer & Friedlander Limited, which is regulated in the United Kingdom by The
Securities and Futures Authority Limited, is acting exclusively for Macmillan,
and  no  one else in connection with the Offer and will not be responsible  to
anyone  other  than  Macmillan,  for providing  the  protections  afforded  to
customers of Singer & Friedlander nor for providing advice in relation to  the
Offer.




The  Offer will not be made, directly or indirectly, in or into, or by use  of
the   mails  or  means  or  instrumentality  (including,  without  limitation,
facsimile transmission, telex or telephone) of interstate or foreign  commerce
of, or any facilities of a national securities exchange of, the United States,
nor will it be made in Canada, Japan or Australia and the Offer should not  be
accepted by any such use, means, instrumentality or facilities or from  within
the United States, Canada, Japan or Australia. Doing so may render invalid any
purported acceptance. Accordingly, copies of this announcement are not  being,
and must not be, mailed or otherwise distributed or sent in or into the United
States, Canada, Japan or Australia.

END

OFFDLMMGZZVLRMM

Cello Health (LSE:CLL)
Historical Stock Chart
From Sep 2024 to Oct 2024

Cello Health (LSE:CLL)
Historical Stock Chart
From Oct 2023 to Oct 2024